We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Novo Nordisk has named Greater Manchester as the 22nd city, and second in the UK, to join Cities Changing Diabetes, a scheme designed to address the dramatic rise of type II diabetes in urban areas.
Marking a UK-first, health and care leaders from Greater Manchester have formed a “pioneering partnership” with the pharmaceutical industry that aims to boost the care and treatment of people with dementia.